Neurology CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection
4 March, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
15 February, 2019
Credits: 0.75 CME
Medical Learning Institute, Inc.
Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
30 January, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
21 December, 2018
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options
13 December, 2018
Credits: 1.25 CME
Medical Learning Institute, Inc.
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
3 December, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
8 November, 2018
Credits: 0.50 CME
Penn State College of Medicine
Assessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis
18 October, 2018
Credits: 1.50 MOC / CME / CE / CPE
Medical Learning Institute, Inc.
Navigating the Expanding Sphingosine-1-Phosphate Receptor Modulator Armamentarium for Multiple Sclerosis Management: Greater Opportunities for Patients With MS
29 June, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU
14 June, 2018
Credits: 1.00 CME / CE / CPE
University of Florida College of Medicine
Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
16 May, 2018